Phenomex stock.

The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to ...All Outstanding Shares of Common Stock . of . PHENOMEX INC. at $1.00 per share, net in cash, without interest . Pursuant to the Offer to Purchase dated August 31, 2023 . by . BIRD MERGERSUB CORPORATION . a wholly-owned subsidiary . of . BRUKER CORPORATIONHistorical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020. View %COMPANY_NAME% CELL investment & stock information. Get the latest %COMPANY_NAME% CELL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction. The proposed acquisition values PhenomeX at a total equity value of approximately $108 million.

15 ago 2023 ... The Arena Group Holdings, Inc. AREN. shares gained 19.5% to $4.0399 after the company announced it signed a binding letter of intent to combine ...PhenomeX stock price target cut to $1 from $3 at Stifel MarketWatch. Thursday, August 17, 2023. 11:27 AM ET. PhenomeX stock rallies by 137% after buyout offer from Bruker MarketWatch. 08:57 AM ET. PhenomeX stock halted pending news MarketWatch. Friday, May 12, 2023. 07:39 AM ET. PheonomeX target price drops to $3 from $10 at Stifel …At the Effective Time, each outstanding option to purchase common stock, par value $0.001, of IsoPlexis (“IsoPlexis Common Stock”) (whether vested or unvested) held by continuing IsoPlexis employees with a per share exercise price less than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one …

Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly-owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), in ...-- Health care stocks extended their Wednesday gains, with the NYSE Health Care Index rising 2.5% this afternoon while the SPDR Health Care Select Sector ETF was up 2.1%. The Nasdaq Biotechnology... | May 11, 2023

Get the latest PhenomeX detailed stock quotes, stock trade data, stock price info, and performance analysis, including PhenomeX Stock investment advice, charts, stats and …WebPhenomeX Inc (CELL). Sector: HEALTH CARE. Industry: BIOTECHNOLOGY & LIFE SCIENCES. SIC: LABORATORY ANALYTICAL ... Stock Lookup. Enter stock name: use * for ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, today announced it will showcase their latest optofluidic and proteomic technologies, along with customer partners, at two upcoming ...

stock-logo-url PhenomeX Inc. flag-US US. US. 0.9981USD. 2 Oct 66. ผลตอบแทน 1 ปี ... PhenomeX Inc. operates as a functional cell biology company. The company ...

The stock market is getting a jolt from the inflation report. All three major U.S. stock indexes jumped more than 1% Tuesday morning, with the coming close to a 2% gain.

Under the Warrant Certificate, the outstanding warrant (the “ IsoPlexis Warrant ”) to purchase shares of common stock, par value $0.001, of IsoPlexis (“ IsoPlexis Common Stock ”), issued by IsoPlexis to Perceptive was assumed by PhenomeX and converted into a warrant (the “ PhenomeX Warrant ”) to purchase shares of common stock, par ...Complete Grid Battery Metals Inc. stock information by Barron's. View real-time CELL stock price and news, along with industry-best analysis.Company profile page for PhenomeX Inc including stock price, company news, press releases, executives, board members, and contact information Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...43.0%. -36.3%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share and multiplying it ...Oct 3, 2023 · During its Q3 2023 earnings release, Bruker will provide more details on the expected Q4 2023 effect from PhenomeX. Today, Bruker reconfirms its medium-term financial outlook as issued at its Investor Day in June 2023. As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market. PhenomeX Inc (CELL). Sector: HEALTH CARE. Industry: BIOTECHNOLOGY & LIFE SCIENCES. SIC: LABORATORY ANALYTICAL ... Stock Lookup. Enter stock name: use * for ...

Mar 21, 2023 · The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol "CELL" at market open tomorrow. Berkeley Lights, Inc. (Nasdaq: BLI ... Acquisition initiates Bruker’s entry into functional single-cell biology research solutions. BILLERICA, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--#BRKR--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction.13 sept 2023 ... PhenomeX Inc. (CELL) Common Shares. Quantity: All PhenomeX Inc. (CELL) Common Shares. Price: $1.00 net cash per share. Expiration: One minute ...PhenomeX Inc. (BLI.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock PhenomeX Inc. | Nyse: BLI | NyseMar 21, 2023 · Recent Highlights. Achieved total revenue of $18.5 million for the first quarter 2023, including: $11.3 million in platform and recurring revenue, including $1.0 million in revenue from IsoPlexis following the closing of the acquisition on March 21, 2023; 8 platform placements, bringing the PhenomeX installed base to 430 platforms; and.

Berkeley Lights, Inc. recently announced the acquisition of IsoPlexis for $57.8 million in an all-stock deal. It will change the combined company name to PhenomeX. It will change the combined ...

Under the Warrant Certificate, the outstanding warrant (the “ IsoPlexis Warrant ”) to purchase shares of common stock, par value $0.001, of IsoPlexis (“ IsoPlexis Common Stock ”), issued by IsoPlexis to Perceptive was assumed by PhenomeX and converted into a warrant (the “ PhenomeX Warrant ”) to purchase shares of common stock, par ...Stock PhenomeX Inc. - Nyse. PhenomeX Inc. (BLI.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock PhenomeX Inc. | …WebPhenomeX was formed earlier this year after Berkeley Lights bought up IsoPlexis, a former Fierce Medtech Fierce 15 winner, and adopted a new moniker through an all-stock transaction valued at $57. ...Berkeley Lights Inc (NASDAQ: BLI) has agreed to acquire IsoPlexis Corp (NASDAQ: ISO) in an all-stock transaction valued at $57.8 million. The combined company, which will be named PhenomeX, will ...Feb 23, 2023 · Recent Highlights. Achieved revenue of $78.6 million for the full year 2022, representing an 8% decrease over the prior year;; Announced the acquisition agreement of IsoPlexis to create a premier functional cell biology company, PhenomeX, when the merger closes, would accelerate the transformation of Berkeley Lights from a technology platform company into a growing, profitable, and sustainable ... IsoPlexis stockholders received 0.612 shares of PhenomeX stock for each IsoPlexis share they held. (2) Includes $ 50 million in principal repayment to retire debt of IsoPlexis, as required by change in control provisions of the debt, as well as prepayment penalties and accrued interest.

Company profile page for PhenomeX Inc including stock price, company news, press releases, executives, board members, and contact information

Oct 3, 2023 · During its Q3 2023 earnings release, Bruker will provide more details on the expected Q4 2023 effect from PhenomeX. Today, Bruker reconfirms its medium-term financial outlook as issued at its Investor Day in June 2023. As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market.

• Calibration and Quality Control Samples: Stock solution of (S)-Amlodipine and (R)-Amlodipine were prepared in methanol at the concentration of 1mg/mL. Working standard solutions of various concentrations for spiking into plasma were prepared with methanol: water (50:50v/v). Working stock of internal standard was prepared at the concentration ofPhenomeX Inc (CELL). Sector: HEALTH CARE. Industry: BIOTECHNOLOGY & LIFE SCIENCES. SIC: LABORATORY ANALYTICAL ... Stock Lookup. Enter stock name: use * for ...Berkeley Lights, Inc. entered into a collaboration with ChemPartner Co., Ltd. focused on accelerating ChemPartner's monoclonal antibody discovery workflow utilizing the Beacon® Optofluidic platform....Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Funding, Valuation & Revenue. 1 Fundings. Phenomenex's latest funding round was a Acquired for on October 12, 2016. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.EMERYVILLE - PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the first quarter ended March 31, 2023. Following the completion of Berkeley Lights' acquisition of IsoPlexis on March 21, 2023, the newly combined company was rebranded as PhenomeX and is positioned to be the leading provider of life sciences solutions that have the greatest impact ...Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020.It's nice to see the PhenomeX Inc. (NASDAQ:CELL) share price up 22% in a week. But that isn't much consolation for the painful drop we've seen in the last year. To wit, the stock has dropped 88% over the last year. It's not uncommon to see a bounce after a drop like that. The bigger issue is whether the company can sustain the momentum in the ...BKD:BERBerlin Stock Exchange · BRKR:DEUGerman Composite · BKD:STUStuttgart Stock ... Bruker Completes Acquisition of PhenomeX October 3, 2023; Bruker Introduces ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...The removal of selected endocrine disrupter compounds (EDCs), namely estrone (E1), 17β-estradiol (E2), 17α-ethynylestradiol (EE2), bisphenol A (BPA) and 4-tert-octylphenol (4t-OP) from municipal wastewater was investigated using a sequencing batch biofilter granular reactor (SBBGR), a new technology for biological treatment based on …TipRanks | Stock Market Research, News and Analyst Forecasts ...Instagram:https://instagram. standard gold bar pricelevel 2 optionsairgsarm stoc Berkeley Lights (Nasdaq: BLI) and IsoPlexis (Nasdaq: ISO) today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.Webull offers Phenomex stock information, including NASDAQ: CELL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and ... vestas wind system stockfranklin finacial Since it has a market capitalisation of US$45m, PhenomeX's US$61m in cash burn equates to about 136% of its market value. That suggests the company may have some funding difficulties, and we'd be ...PhenomeX Inc. (Name of Subject Company) PhenomeX Inc. (Name of Persons Filing Statement) Common Stock, $0.00005 par value per share (Title of Class of Securities) 084310101 (CUSIP Number of Class of Securities) Scott Chaplin Chief Legal Officer PhenomeX Inc. 5858 Horton Street, Suite 320 Emeryville, California, 94608 (510) 858-2855 jpm futures Dec 22, 2022 · Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million. 6 oct 2023 ... NEW YORK – Pacific Biosciences announced this week the resale of up to approximately 9 million shares of common stock ... PhenomeX for $108 ...PhenomeX Inc. has emerged as a leader in the field of biotechnology, revolutionizing the way we approach healthcare and scientific research. The success story of this groundbreaking company is a testament to the vision and dedication of its founders. PhenomeX Inc. was founded in 2005 by a group of brilliant scientists and entrepreneurs who ...